These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30188604)

  • 21. Nonalcoholic fatty liver disease increases the risk of hepatocellular carcinoma in patients with alcohol-associated cirrhosis awaiting liver transplants.
    Pais R; Lebray P; Rousseau G; Charlotte F; Esselma G; Savier E; Thabut D; Rudler M; Eyraud D; Vezinet C; Siksik JM; Vaillant JC; Hannoun L; Poynard T; Ratziu V
    Clin Gastroenterol Hepatol; 2015 May; 13(5):992-9.e2. PubMed ID: 25459558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics of alcoholic liver disease and predictive factors for mortality of patients with alcoholic cirrhosis.
    Xie YD; Feng B; Gao Y; Wei L
    Hepatobiliary Pancreat Dis Int; 2013 Dec; 12(6):594-601. PubMed ID: 24322744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changing Trends in Liver Cirrhosis Etiology and Severity in Korea: the Increasing Impact of Alcohol.
    Yoon JH; Jun CH; Kim JH; Yoon EL; Kim BS; Song JE; Suk KT; Kim MY; Kang SH
    J Korean Med Sci; 2021 May; 36(21):e145. PubMed ID: 34060260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low to moderate lifetime alcohol consumption is associated with less advanced stages of fibrosis in non-alcoholic fatty liver disease.
    Hagström H; Nasr P; Ekstedt M; Kechagias S; Önnerhag K; Nilsson E; Rorsman F; Sheikhi R; Marschall HU; Hultcrantz R; Stål P
    Scand J Gastroenterol; 2017 Feb; 52(2):159-165. PubMed ID: 27650916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: A large Dutch population cohort.
    van den Berg EH; Amini M; Schreuder TC; Dullaart RP; Faber KN; Alizadeh BZ; Blokzijl H
    PLoS One; 2017; 12(2):e0171502. PubMed ID: 28152105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Demographic and Clinical Profile in Patients with Liver Cirrhosis in a Tertiary Care Hospital in Central Nepal.
    Bhattarai S; Gyawali M; Dewan KR; Shrestha G
    JNMA J Nepal Med Assoc; 2017; 56(208):401-6. PubMed ID: 29453469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leukocyte arylsulfatase A activity in patients with alcohol-related cirrhosis.
    Alvarez-Leal M; Contreras-Hernández D; Chávez A; Diaz-Contreras JA; Careaga-Olivares J; Zúñiga-Charles MA; Reynoso MC; Hernández-Téllez A
    Am J Hum Biol; 2001; 13(3):297-300. PubMed ID: 11460894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Alcoholic cirrhosis. Pathologic anatomy, diagnosis, complications and their physiopathology, treatment].
    Doffoël M
    Rev Prat; 1999 Feb; 49(3):320-6. PubMed ID: 10189803
    [No Abstract]   [Full Text] [Related]  

  • 29. Prospective evaluation of alcohol abuse and alcoholic liver injury in men as predictors of development of cirrhosis.
    Sørensen TI; Orholm M; Bentsen KD; Høybye G; Eghøje K; Christoffersen P
    Lancet; 1984 Aug; 2(8397):241-4. PubMed ID: 6146805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patients with alcohol-related liver disease hospitalized during the COVID-19 pandemic experienced worse outcomes.
    Sobotka LA; Jain A; Peng J; Allen KD; McShane CJ; Ramsey ML; Wellner MR; Kirkpatrick RB
    Ann Hepatol; 2023; 28(3):101088. PubMed ID: 36933885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modest alcohol consumption and carotid plaques or carotid artery stenosis in men with non-alcoholic fatty liver disease.
    Sinn DH; Gwak GY; Cho J; Son HJ; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    Atherosclerosis; 2014 Jun; 234(2):270-5. PubMed ID: 24704629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hepatic transit times and liver elasticity compared with meld in predicting a 1 year adverse clinical outcome of a clinically diagnosed cirrhosis].
    Koller T; Piešťanská Z; Hlavatý T; Holomáň J; Glasa J; Payer J
    Vnitr Lek; 2016; 62(5):351-9. PubMed ID: 27319227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nutritional assessment in various stages of liver cirrhosis.
    Roongpisuthipong C; Sobhonslidsuk A; Nantiruj K; Songchitsomboon S
    Nutrition; 2001 Sep; 17(9):761-5. PubMed ID: 11527674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term prognosis of patients with alcohol-related liver disease or non-alcoholic fatty liver disease according to metabolic syndrome or alcohol use.
    Decraecker M; Dutartre D; Hiriart JB; Irles-Depé M; Marraud des Grottes H; Chermak F; Foucher J; Delamarre A; de Ledinghen V
    Liver Int; 2022 Feb; 42(2):350-362. PubMed ID: 34679242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The MELD score in advanced liver disease: association with clinical portal hypertension and mortality.
    Saab S; Landaverde C; Ibrahim AB; Durazo F; Han S; Yersiz H; Farmer DG; Ghobrial RM; Goldstein LI; Tong MJ; Busuttil RW
    Exp Clin Transplant; 2006 Jun; 4(1):395-9. PubMed ID: 16827633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study.
    Vilar-Gomez E; Calzadilla-Bertot L; Wai-Sun Wong V; Castellanos M; Aller-de la Fuente R; Metwally M; Eslam M; Gonzalez-Fabian L; Alvarez-Quiñones Sanz M; Conde-Martin AF; De Boer B; McLeod D; Hung Chan AW; Chalasani N; George J; Adams LA; Romero-Gomez M
    Gastroenterology; 2018 Aug; 155(2):443-457.e17. PubMed ID: 29733831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Statin use is not associated with presence of and severity of nonalcoholic fatty liver disease.
    Oni ET; Sinha P; Karim A; Martin SS; Blaha MJ; Agatston AS; Blumenthal RS; Meneghelo RS; Conceiçao RD; Santos RD; Nasir K
    Arch Med Res; 2014 Jan; 45(1):52-7. PubMed ID: 24333254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis.
    Ganne-Carrié N; Chaffaut C; Bourcier V; Archambeaud I; Perarnau JM; Oberti F; Roulot D; Moreno C; Louvet A; Dao T; Moirand R; Goria O; Nguyen-Khac E; Carbonell N; Antonini T; Pol S; de Ledinghen V; Ozenne V; Henrion J; Péron JM; Tran A; Perlemuter G; Amiot X; Zarski JP; Beaugrand M; Chevret S;
    J Hepatol; 2018 Dec; 69(6):1274-1283. PubMed ID: 30092234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sex and age differences in the early identification and treatment of alcohol use: a population-based study of patients with alcoholic cirrhosis.
    Otete HE; Orton E; West J; Fleming KM
    Addiction; 2015 Dec; 110(12):1932-40. PubMed ID: 26235801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diabetes impacts prediction of cirrhosis and prognosis by non-invasive fibrosis models in non-alcoholic fatty liver disease.
    Bertot LC; Jeffrey GP; de Boer B; MacQuillan G; Garas G; Chin J; Huang Y; Adams LA
    Liver Int; 2018 Oct; 38(10):1793-1802. PubMed ID: 29575516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.